1. You are here:
  2. Research
  3. Research Articles
  4. 2012 Articles

2012 Articles

Pharmacokinetic assessment of ketanserin in the horse.
Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD.
J. Vet. Pharmacol. Ther., 2012, 35, 472–477.

A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
Bailly-Chouriberry L, Cormant F, Garcia P, Lönnberg M, Szwandt S, Bondesson U, Popot MA, Bonnaire Y.
Analyst, 2012, 137, 2445–2453.

Liquid chromatography tandem mass spectrometry determination of total budesonide levels in dog plasma after inhalation exposure.
Berg S, Melamies M, Rajamäki M, Vainio O, Peltonen K.
Anal. Bioanal. Chem., 2012, 402, 1209–1215.

Preliminary pharmacokinetics and cardiovascular effects of fenoldopam continuous rate infusion in six healthy dogs.
Bloom CA, Labato MA, Hazarika S, Court MH.
J. Vet. Pharmacol. Ther., 2012, 35, 224–230.

Validation of a chiral liquid chromatography-tandem mass spectrometry method for the determination of pantoprazole in dog plasma.
Chen M, Xia Y, Ma Z, Li L, Zhong D, Chen X.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2012, 906, 85–90.

Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
Cox S, Dudenbostel L, Sommardahl C, Yarbrough J, Saleh M, Doherty T.
J. Vet. Pharmacol. Ther., 2012, 35, 615–617.

Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Davis JL, Messenger KM, LaFevers DH, Barlow BM, Posner LP.
J. Vet. Pharmacol. Ther., 2012, 35, 52–58.

Investigation of the presence of endogenous prednisolone in equine urine by high-performance liquid chromatography mass spectrometry and high-resolution mass spectrometry.
Fidani M, Pompa G, Mungiguerra F, Casati A, Fracchiolla ML, Arioli F.
Rapid Commun. Mass Spectrom., 2012, 26, 879–886.

Population pharmacokinetics of transdermal fentanyl solution following a single dose administered prior to soft tissue and orthopedic surgery in dogs.
Freise KJ, Linton DD, Newbound GC, Tudan C, Clark TP.
J. Vet. Pharmacol. Ther., 2012, 35, Supp 2, 65–72.

Pharmacokinetics and the effect of application site on a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
Freise KJ, Newbound GC, Tudan C, Clark TP.
J. Vet. Pharmacol. Ther., 2012, 35, Supp 2, 27–33.

Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
Friese KJ, Savides MC, Riggs KL, Owens JG, Newbound GC.
J. Vet. Pharmacol. Ther., 2012, 35, Supp 2, 21–26.

Quantitative analysis of a quaternary ammonium drug: ipratropium bromide by LC/ESI-MSn in horse plasma and urine.
Garcia P, Paris AC, Leufroy A, Popot MA, Bonnaire Y.
Biomed. Chromatogr., 2012, 26, 534–540.

Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs.
Giorgi M, Meizler A, Mills PC.
Vet. J., 2012, 194, 309–313.

Pharmacokinetics of mirtazapine and its main metabolites in beagle dogs: a pilot study.
Giorgi M, Yun H.
Vet. J., 2012, 192, 239–241.

Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse.
Grimsrud KN, Mama KR, Steffey EP, Stanley SD.
Vet. Anaesth. Analg., 2012, 39, 38–48.

Ex vivo spontaneous generation of 19-norandrostenedione and nandrolone detected in equine plasma and urine.
Guan F, Uboh CE, Soma LR, You Y, Li X, McDonnell S.
J. Steroid Biochem. Mol. Biol., 2012, 128, 1–11.

Daily endogenous cortisol production and hydrocortisone pharmacokinetics in adult horses and neonatal foals.
Hart KA, Dirikolu L, Ferguson DC, Norton NA, Barton MH.
Am. J. Vet. Res., 2012, 73, 68–75.

Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography–mass spectrometry.
Ho ENM, Kwok WH, Lau MY, Wong ASY, Wan TSM, Lam KKH, Schiff PJ, Stewart BD.
J. Chromatogr. A, 2012, 1265, 57–69.

The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.
Knych HK, Steffey EP, Stanley SD.
Vet. Anaesth. Analg., 2012, 39, 221–229.

Pharmacokinetics of the cytochrome P-450 substrates phenytoin, theophylline, and diazepam in healthy greyhound dogs.
Kukanich B, Nauss JL.
J. Vet. Pharmacol. Ther., 2012, 35, 275–281.

Rapid and Sensitive LC-MS/MS Method for the Determination of Metoprolol in Beagle Dog Plasma with a Simple Protein Precipitation Treatment and Its Pharmacokinetic Applications.
Li S, Wang X, Peng K, Ma Z, Zhang X, Fu S, Li X, Li L, Hong A, Jiang J.
Molecules, 2012, 5, 2663–2674.

Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR.
Am. J. Vet. Res., 2012, 73, 290–295.

The development and validation of a turbulent flow chromatography–tandem mass spectrometry method for the endogenous steroid profiling of equine serum.
Moeller BC, Stanley SD.
J. Chromatogr. B Biomed. Analyt. Technol. Biomed. Life Sci., 2012, 905, 1–9.

Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M.
Eur. J. Mass Spectrom., 2012, 18, 407–412.

Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.
Muzzio M, Huang Z, Hu SC, Johnson WD, McCormick DL, Kapetanovic IM.
J. Pharm. Biomed. Anal., 2012, 59, 201–208.

Simultaneous determination of zolazepam and tiletamine in dog plasma by liquid chromatography coupled to a tandem mass spectrometry.
Noh K, Kim KS, Ahn B, Archimbault P, Oh TH, Kang W.
Biomed. Chromatogr., 2012, 26, 1133–1136.

Pharmacokinetics of gallium nitrate after oral administration in adult horses – pilot study.
Pollina GF, Zagotto G, Maritan P, Iacopetti I, Busetto R.
J. Vet. Pharmacol. Ther., 2012, 35, 489–494.

Regulatory control of glycopyrrolate in performance horses using validated UHPLC/MS-MS methods.
Rumpler MJ, Sams RA, Colahan P.
J. Chromatogr. B Biomed. Analyt. Technol. Biomed. Life Sci., 2012, 889-890, 130–137.

Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry.
Rydevik A, Bondesson U, Hedeland M.
Rapid Commun. Mass Spectrom., 2012, 26, 1338–1346.

Simultaneous determination of levocetirizine and pseudoephedrine in dog plasma by liquid chromatography-mass spectrometry in the presence of dextrocetirizine.
Ryu JK, Yoo SD.
J. Pharm. Pharm. Sci. A, 2012, 15, 519–527.

The use of phenylbutazone in the horse.
Soma LR, Uboh CE, Maylin GM.
J. Vet. Pharmacol. Ther., 2012, 35, 1–12.

Effect of sample handling and storage time on the stability of total CO2 in equine plasma.
Tinkler SH, Couëtil LL, Constable PD.
Equine Vet. J., 2012, 44 Suppl. 43, 57–61.

Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-tandem mass spectrometry.
Wang CC, Hartmann-Fischbach P, Krueger TR, Wells TL, Feineman AR, Compton JC.
J. Anal. Toxicol., 2012, 36, 327–333.

Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Waxman SJ, Kukanich B, Milligan M, Beard WL, Davis EG.
J. Vet. Pharmacol. Ther., 2012, 35, 413–416.

Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs.
Whiterock VJ, Morgan DG, Lentz KA, Orcutt TL, Sinz MW.
Drug Metab. Dispos., 2012, 40, 228–231.

Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Wojtasiak-Wypart M, Soma LR, Rudy JA, Uboh CE, Boston RC, Driessen B.
J. Vet. Pharmacol. Ther., 2012, 35, 478–488.

Detection of myo-inositol trispyrophosphate in equine urine and plasma by hydrophillic interaction chromatography-tandem mass spectrometry.
Wong ASY, Ho ENM, Wan TSM.
Drug Test. Anal., 2012, 4, 355–361.

Rapid screening of anabolic steroids in horse urine with ultra-high-performance liquid chromatography/tandem mass spectrometry after chemical derivatisation.
Wong CH, Leung DK, Tang FP, Wong JK, Yu NH, Wan TS.
J. Chromatogr. A, 2012, 1232, 257–265.

Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.
Yaksh TL, de Kater A, Dean R, Best BM, Miljanich GP.
Neuromodulation, 2012, 15, 508–519.

Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs.
Zou W, Liu M, Yang C, Peng W, Su W.
Biopharm. Drug Disp., 2012, 33, 123–134.